Update : November 14, 2008    
Left main coronary
disease
Ostial disease
Bifurcation
Graft vessel disease
Diffuse coronary
disease
Chronic total
occlusion (CTO)
Restenosis
Multivessel disease
Drug eluting stent
Vulnerable plaque
Angioplasty Summit 2003 : Expert Lectures

Expert Lectures
 
  Drug Eluting Stents: All Patients vs Selective Use? Alan C. Yeung, MD
 
IVUS Findings in Acute Coronary Syndrome

Gary S. Mintz, MD
  IVUS Findings in Restenosis: From PTCA to Drug Eluting Stent Gary S. Mintz, MD
  Angioplasty for Chronic Total Occlusion Shigeru Saito, MD
 
Angiomyogenesis Symposium
 
    Two Kinds of Endothelial Progenitor Cells and Their Genetic Modification to Enhance Vasculogenesis for Ischemia Hyo Soo Kim, MD
    Biobypass Angiogenic Gene Therapy in Patients with PAOD Duk-Kyung Kim, MD
 
Luncheon Session
 
    Vascular Brachytherapy in the Real World: in the Era of Drug Eluting Stenting Alan C. Yeung, MD
    New Bifurcation Stent – Long Term Outcomes Alan C. Yeung, MD
 
|   About summitMD.com   |   Newsletter Archive   |   Submit a Case   |   Contact us   |

Copyright © 2002 CVRF, Seoul, Korea. All rights reserved.